Major Depressive Disorder KOL Interview – UK

Major Depressive Disorder KOL Interview – UK

  • December 2018 •
  • 11 pages •
  • Report ID: 5780041 •
  • Format: PDF
Overview
A UK key opinion leader (KOL) provides insight into the critical unmet needs in the depression market, along with future trends. Key late-phase pipeline drugs for major depressive disorder and post-partum depression are covered, with particular focus on Johnson and Johnson’s esketamine.